| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | THSD4 RELN COL6A5 COL24A1 ANOS1 PXDN SCARA3 LAMA4 MUC3A MUC4 | 5.62e-05 | 188 | 225 | 10 | GO:0005201 |
| GeneOntologyCellularComponent | COPI-coated Golgi to ER transport vesicle | 1.16e-04 | 2 | 226 | 2 | GO:0030142 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 RELN IL16 LGALS9B COL6A5 COL24A1 ANOS1 PXDN ANGPT4 NAV2 ADAMTS18 SCARA3 LAMA4 LINGO2 LGALS9 ENTPD2 MUC4 SERPINA5 | 2.95e-04 | 656 | 226 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 RELN IL16 LGALS9B COL6A5 COL24A1 ANOS1 PXDN ANGPT4 NAV2 ADAMTS18 SCARA3 LAMA4 LINGO2 LGALS9 ENTPD2 MUC4 SERPINA5 | 3.06e-04 | 658 | 226 | 18 | GO:0030312 |
| HumanPheno | Hyperactive renin-angiotensin system | 3.50e-08 | 8 | 76 | 5 | HP:0000841 | |
| HumanPheno | Hypochloremia | 1.55e-06 | 7 | 76 | 4 | HP:0003113 | |
| HumanPheno | Increased circulating aldosterone concentration | 6.02e-06 | 32 | 76 | 6 | HP:0000859 | |
| HumanPheno | Increased circulating renin concentration | 6.39e-06 | 19 | 76 | 5 | HP:0000848 | |
| HumanPheno | Abnormal circulating renin concentration | 7.27e-06 | 33 | 76 | 6 | HP:0040084 | |
| HumanPheno | Abnormal urine chloride concentration | 3.12e-05 | 5 | 76 | 3 | HP:0012600 | |
| HumanPheno | Hyperchloriduria | 3.12e-05 | 5 | 76 | 3 | HP:0002914 | |
| HumanPheno | Abnormality of aldosterone production | 4.07e-05 | 44 | 76 | 6 | HP:0002855 | |
| HumanPheno | Abnormality of adrenal physiology | GATB GK CLCNKA CLCNKB NR3C2 GNAS HERC2 SLC26A3 SLC12A1 ROBO1 | 6.18e-05 | 149 | 76 | 10 | HP:0011733 |
| HumanPheno | Abnormal circulating prostaglandin circulation | 6.18e-05 | 6 | 76 | 3 | HP:0011023 | |
| HumanPheno | Hyperprostaglandinuria | 6.18e-05 | 6 | 76 | 3 | HP:0003527 | |
| HumanPheno | Abnormal circulating aldosterone concentration | 9.55e-05 | 51 | 76 | 6 | HP:0040085 | |
| HumanPheno | Metabolic alkalosis | 1.20e-04 | 18 | 76 | 4 | HP:0200114 | |
| HumanPheno | Adrenocortical abnormality | 1.30e-04 | 77 | 76 | 7 | HP:0000849 | |
| HumanPheno | Abnormality of renin-angiotensin system | 1.47e-04 | 55 | 76 | 6 | HP:0000847 | |
| HumanPheno | Adrenal overactivity | 1.47e-04 | 55 | 76 | 6 | HP:0002717 | |
| HumanPheno | Abnormal circulating unsaturated fatty acid concentration | 1.69e-04 | 8 | 76 | 3 | HP:0011022 | |
| HumanPheno | Abnormal circulating eicosanoid concentration | 1.69e-04 | 8 | 76 | 3 | HP:0030361 | |
| HumanPheno | Hyperostosis frontalis interna | 2.20e-04 | 2 | 76 | 2 | HP:0004438 | |
| HumanPheno | Hypokalemic metabolic alkalosis | 2.51e-04 | 9 | 76 | 3 | HP:0001960 | |
| HumanPheno | Increased urinary potassium | 2.51e-04 | 9 | 76 | 3 | HP:0003081 | |
| Domain | ConA-like_dom | TRIML1 LGALS9B ADGRG4 COL24A1 HERC1 FAT3 RNF135 TSPEAR LAMA4 MAMDC4 LGALS9 ADGRD2 PROS1 | 2.67e-06 | 219 | 225 | 13 | IPR013320 |
| Domain | WD40_repeat_dom | ARHGEF17 SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 UBR4 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 3.37e-06 | 297 | 225 | 15 | IPR017986 |
| Domain | WD40_repeat | SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 5.79e-06 | 272 | 225 | 14 | IPR001680 |
| Domain | WD_REPEATS_1 | SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 7.43e-06 | 278 | 225 | 14 | PS00678 |
| Domain | WD_REPEATS_2 | SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 7.74e-06 | 279 | 225 | 14 | PS50082 |
| Domain | WD_REPEATS_REGION | SHKBP1 PIK3R4 HERC2 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 7.74e-06 | 279 | 225 | 14 | PS50294 |
| Domain | WD40 | SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 1.64e-05 | 259 | 225 | 13 | PF00400 |
| Domain | WD40 | SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 2.35e-05 | 268 | 225 | 13 | SM00320 |
| Domain | - | ARHGEF17 SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 5.50e-05 | 333 | 225 | 14 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | ARHGEF17 SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 5.86e-05 | 335 | 225 | 14 | IPR015943 |
| Domain | Cl_channel-K | 1.44e-04 | 2 | 225 | 2 | IPR002250 | |
| Domain | - | 1.51e-04 | 95 | 225 | 7 | 2.60.120.200 | |
| Domain | PFKB_KINASES_2 | 4.30e-04 | 3 | 225 | 2 | PS00584 | |
| Domain | Carboh/pur_kinase_PfkB_CS | 4.30e-04 | 3 | 225 | 2 | IPR002173 | |
| Domain | ALMS_motif | 4.30e-04 | 3 | 225 | 2 | IPR029299 | |
| Domain | ALMS_motif | 4.30e-04 | 3 | 225 | 2 | PF15309 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.52e-05 | 26 | 176 | 5 | M27483 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 3.80e-05 | 16 | 176 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 4.92e-05 | 17 | 176 | 4 | M27412 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.52e-04 | 9 | 176 | 3 | M27344 | |
| Pathway | REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS | 1.52e-04 | 9 | 176 | 3 | MM15084 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.73e-04 | 23 | 176 | 4 | M556 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.01e-04 | 68 | 176 | 6 | M27303 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.93e-04 | 11 | 176 | 3 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.93e-04 | 11 | 176 | 3 | M26913 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM3B TAB2 ARHGEF17 SHKBP1 PIK3R4 KCNQ5 ALMS1 STARD9 SVIL NAV2 KMT2A COBL NR3C2 GNAS KDM5A RAB11FIP1 CDC14A FAM83B GRIP1 VPS13D CCDC88A SIPA1L1 AKAP13 SH3RF3 PLK4 SAMD4A EXOC4 | 2.21e-11 | 861 | 228 | 27 | 36931259 |
| Pubmed | ATP5PO GATAD2A USP11 RC3H1 FLG2 INO80D ALMS1 SVIL KMT2A ZNF770 MLLT6 HERC2 HERC1 TAF1L HOMEZ NPAT CNOT11 NUP107 KDM5A RBM33 RBBP5 UBR4 PHF6 POU2F1 ZMIZ1 EXOC4 | 2.85e-06 | 1429 | 228 | 26 | 35140242 | |
| Pubmed | KIF18A CTU2 IL16 SAV1 TAB2 COL24A1 SVIL MLLT6 TAF1L RUSF1 RAD17 CNOT11 UBR4 ADNP2 ROBO2 AKAP13 SAMD4A | 3.54e-06 | 689 | 228 | 17 | 36543142 | |
| Pubmed | KCNQ5 ALMS1 STARD9 DNAJB2 CACNA1E UBR4 DNAH2 CEP295 MAPK8IP2 ZNF292 | 3.60e-06 | 233 | 228 | 10 | 37704626 | |
| Pubmed | CABLES1 COBL CKAP4 CACNB2 RAB11FIP1 FAM83B JPH1 GRIP1 CCDC88A KIRREL1 ROBO1 ROBO2 EXOC4 | 4.86e-06 | 421 | 228 | 13 | 36976175 | |
| Pubmed | 5.48e-06 | 6 | 228 | 3 | 28394331 | ||
| Pubmed | The role of Robo3 in the development of cortical interneurons. | 5.48e-06 | 6 | 228 | 3 | 19366869 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ATP5PO USP11 GATB FLG2 SPTBN5 GK ALMS1 SLAIN1 CKAP4 GNAS HERC2 HERC1 PHIP WDR36 NUP107 RBM33 PCLO UBR4 BIRC2 FAM83B NCOA5 JPH1 VPS13D UTP18 FIGNL1 EXOC4 | 6.44e-06 | 1496 | 228 | 26 | 32877691 |
| Pubmed | KDM3B SAV1 KLHL9 ALMS1 CKAP4 RUSF1 SLC27A4 RBM33 JPH1 CCDC88A DDHD1 TTLL4 KIRREL1 ROBO1 AKAP13 CEP295 ELP4 | 7.97e-06 | 733 | 228 | 17 | 34672954 | |
| Pubmed | Impairment in renal medulla development underlies salt wasting in Clc-k2 channel deficiency. | 9.55e-06 | 7 | 228 | 3 | 34499620 | |
| Pubmed | Intrarenal and cellular localization of CLC-K2 protein in the mouse kidney. | 9.55e-06 | 7 | 228 | 3 | 11423561 | |
| Pubmed | TAB2 POM121 ALMS1 SVIL NUP107 RBM33 FAM83B CCDC88A KIRREL1 EXOC4 | 1.04e-05 | 263 | 228 | 10 | 34702444 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | THSD4 IL16 PDE4B SWT1 ZNF236 COBL POU2F1 LINGO2 ROBO2 UNC13C | 1.11e-05 | 265 | 228 | 10 | 19240061 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GATAD2A KDM3B MYSM1 KMT2A ZNF770 MLLT6 HERC2 PHIP HOMEZ NPAT KDM5A RBBP5 ADNP2 POU2F1 ZNF292 | 1.34e-05 | 608 | 228 | 15 | 36089195 |
| Pubmed | Trio GEF mediates RhoA activation downstream of Slit2 and coordinates telencephalic wiring. | 1.52e-05 | 8 | 228 | 3 | 30177526 | |
| Pubmed | 2.19e-05 | 175 | 228 | 8 | 28071719 | ||
| Pubmed | 2.27e-05 | 9 | 228 | 3 | 15199122 | ||
| Pubmed | PDE4B ARHGAP15 TAB2 CLCNKA ADAMTS18 CRYBG1 HERC1 ARHGEF6 RAD17 NPAT CACNB2 FAM210A MPEG1 CUBN SEC24C DDHD1 SIPA1L1 TTLL4 OR10AD1 CEP295 | 3.49e-05 | 1084 | 228 | 20 | 11544199 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 26132276 | ||
| Pubmed | The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. | 4.28e-05 | 2 | 228 | 2 | 27335120 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 8812470 | ||
| Pubmed | Robo signaling regulates the production of cranial neural crest cells. | 4.28e-05 | 2 | 228 | 2 | 28987541 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 25919862 | ||
| Pubmed | NTPDase2 and the P2Y1 receptor are not required for mammalian eye formation. | 4.28e-05 | 2 | 228 | 2 | 25504514 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 10465427 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 31597096 | ||
| Pubmed | Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss. | 4.28e-05 | 2 | 228 | 2 | 38069401 | |
| Pubmed | Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression. | 4.28e-05 | 2 | 228 | 2 | 34958665 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 18022324 | ||
| Pubmed | Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans. | 4.28e-05 | 2 | 228 | 2 | 22649195 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 10066897 | ||
| Pubmed | A regulatory calcium-binding site at the subunit interface of CLC-K kidney chloride channels. | 4.28e-05 | 2 | 228 | 2 | 20805576 | |
| Pubmed | Robo1/2 regulate follicle atresia through manipulating granulosa cell apoptosis in mice. | 4.28e-05 | 2 | 228 | 2 | 25988316 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 23544943 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 9458045 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 14762176 | ||
| Pubmed | Salt wasting and deafness resulting from mutations in two chloride channels. | 4.28e-05 | 2 | 228 | 2 | 15044642 | |
| Pubmed | Two highly homologous members of the ClC chloride channel family in both rat and human kidney. | 4.28e-05 | 2 | 228 | 2 | 8041726 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 30778771 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 35584116 | ||
| Pubmed | A cytoplasmic domain mutation in ClC-Kb affects long-distance communication across the membrane. | 4.28e-05 | 2 | 228 | 2 | 18648499 | |
| Pubmed | Cloning, tissue distribution, and intrarenal localization of ClC chloride channels in human kidney. | 4.28e-05 | 2 | 228 | 2 | 8544406 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 24863058 | ||
| Pubmed | Overt nephrogenic diabetes insipidus in mice lacking the CLC-K1 chloride channel. | 4.28e-05 | 2 | 228 | 2 | 9916798 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 9916791 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 35177623 | ||
| Pubmed | Robo1 and Robo2 are homophilic binding molecules that promote axonal growth. | 4.28e-05 | 2 | 228 | 2 | 12504588 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 30022126 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 34146541 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 22862946 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 26608094 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 24440830 | ||
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 24247621 | ||
| Pubmed | ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits. | 4.28e-05 | 2 | 228 | 2 | 30421101 | |
| Pubmed | 4.28e-05 | 2 | 228 | 2 | 11014860 | ||
| Pubmed | A genome-wide association study identifies protein quantitative trait loci (pQTLs). | 5.11e-05 | 61 | 228 | 5 | 18464913 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SLC39A9 TAB2 KLHL9 ALMS1 SVIL COBL HERC2 DYNC2I2 RNF135 NUP43 FAM83B GRIP1 CCDC88A WASF2 SIPA1L1 CEP295 EXOC4 | 5.39e-05 | 853 | 228 | 17 | 28718761 |
| Pubmed | 5.86e-05 | 12 | 228 | 3 | 23684652 | ||
| Pubmed | 7.15e-05 | 153 | 228 | 7 | 10718198 | ||
| Pubmed | CDK19 ARHGEF17 CSMD3 KIRREL3 PXDN STARD9 COBL PHF6 SEC24C SIPA1L1 RUBCN | 8.69e-05 | 407 | 228 | 11 | 12693553 | |
| Pubmed | DLGAP1 POM121 NAV2 COBL HERC2 RBM33 ADNP2 LAMA4 USF3 CCDC88A ROBO1 AKAP13 | 9.81e-05 | 486 | 228 | 12 | 20936779 | |
| Pubmed | 1.19e-04 | 15 | 228 | 3 | 20188150 | ||
| Pubmed | 1.19e-04 | 15 | 228 | 3 | 24453333 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CABLES1 PIK3R4 NAV2 KMT2A COBL HERC1 RBM33 VPS13D IGHMBP2 MUC4 SH3RF3 ZNF292 | 1.21e-04 | 497 | 228 | 12 | 36774506 |
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 15768400 | ||
| Pubmed | Human CLC-K Channels Require Palmitoylation of Their Accessory Subunit Barttin to Be Functional. | 1.28e-04 | 3 | 228 | 2 | 26013830 | |
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 19776007 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 16397580 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 20439316 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 23053434 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 33316546 | ||
| Pubmed | Barttin increases surface expression and changes current properties of ClC-K channels. | 1.28e-04 | 3 | 228 | 2 | 12111250 | |
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 14678835 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 14689480 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 9038233 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 26745454 | ||
| Pubmed | Slit2-Robo Signaling Promotes Glomerular Vascularization and Nephron Development. | 1.28e-04 | 3 | 228 | 2 | 34341180 | |
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 28704475 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 18272390 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 30236127 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 17510212 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 1.28e-04 | 3 | 228 | 2 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 1.28e-04 | 3 | 228 | 2 | 22341088 | |
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 32380082 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 23667648 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 19187761 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 28877989 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 19800850 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 38987795 | ||
| Pubmed | ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling. | 1.28e-04 | 3 | 228 | 2 | 30504844 | |
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 18466743 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 23266085 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 37105392 | ||
| Pubmed | Allelic-based gene-gene interaction associated with quantitative traits. | 1.28e-04 | 3 | 228 | 2 | 19058262 | |
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 36479526 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 21531981 | ||
| Pubmed | 1.28e-04 | 3 | 228 | 2 | 23242525 | ||
| Pubmed | Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. | 1.28e-04 | 3 | 228 | 2 | 19851072 | |
| Pubmed | The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes. | 1.28e-04 | 3 | 228 | 2 | 33923930 | |
| Interaction | YWHAH interactions | DLGAP1 KDM3B SAV1 TAB2 ARHGEF17 SHKBP1 PIK3R4 KCNQ5 ALMS1 STARD9 SVIL NAV2 KMT2A COBL SLAIN1 NR3C2 HERC1 ARHGEF6 HOMEZ KDM5A RAB11FIP1 CDC14A FAM83B GRIP1 VPS13D CCDC88A WASF2 SIPA1L1 AKAP13 SH3RF3 PLK4 RUBCN SAMD4A EXOC4 | 5.66e-08 | 1102 | 223 | 34 | int:YWHAH |
| Interaction | YWHAG interactions | DLGAP1 RC3H1 KDM3B TAB2 ARHGEF17 SHKBP1 PIK3R4 KCNQ5 ALMS1 STARD9 SVIL NAV2 KMT2A COBL SLAIN1 GNAS ARHGEF6 HOMEZ RAB11FIP1 CDC14A FAM83B GRIP1 VPS13D CCDC88A WASF2 SIPA1L1 AKAP13 SH3RF3 PLK4 RUBCN SAMD4A EXOC4 | 7.78e-06 | 1248 | 223 | 32 | int:YWHAG |
| GeneFamily | WD repeat domain containing | SHKBP1 PIK3R4 HERC1 PHIP NSMAF WDR36 DYNC2I2 RBBP5 NUP43 AMBRA1 SEC31B UTP18 DNAI4 | 1.14e-06 | 262 | 169 | 13 | 362 |
| GeneFamily | CD molecules|Mucins | 3.89e-05 | 21 | 169 | 4 | 648 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.38e-04 | 161 | 169 | 8 | 593 | |
| GeneFamily | Solute carriers | SLC39A9 SLC28A3 SLC15A3 SLC41A2 SLC35D3 SLC5A12 SLC27A4 SLC26A3 SLC12A1 SLC26A7 SLC18A1 SLCO1A2 | 3.50e-04 | 395 | 169 | 12 | 752 |
| GeneFamily | WD repeat domain containing|UTPB complex | 1.27e-03 | 6 | 169 | 2 | 1225 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.78e-03 | 26 | 169 | 3 | 253 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.99e-03 | 27 | 169 | 3 | 1253 | |
| GeneFamily | Zinc fingers AN1-type|UPF1 like RNA helicases | 2.34e-03 | 8 | 169 | 2 | 63 | |
| GeneFamily | Nucleoporins | 3.26e-03 | 32 | 169 | 3 | 1051 | |
| GeneFamily | Chloride voltage-gated channels | 3.72e-03 | 10 | 169 | 2 | 302 | |
| GeneFamily | Ring finger proteins | 4.40e-03 | 275 | 169 | 8 | 58 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.57e-03 | 36 | 169 | 3 | 823 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | IL16 PDE4B ARHGAP15 INPP4A TAB2 INO80D MYSM1 NXPE3 NEDD9 KMT2A CRYBG1 MLLT6 GNAS HERC1 PHIP ARHGEF6 NSMAF NPAT PLAAT4 KDM5A RNF19A RBM33 RBL2 UBR4 BIRC2 CDC14A HIVEP3 CCDC88A IPCEF1 AKAP13 ZNF292 | 4.79e-06 | 1492 | 225 | 31 | M40023 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | NEXMIF KMT2A ARHGAP20 UNC79 CACNA1E CACNB1 RBM33 PCLO TMEM151B SEC31B MAMDC4 IGHMBP2 MYO16 MAPK8IP2 | 7.62e-06 | 389 | 225 | 14 | M39102 |
| Coexpression | LEE_DIFFERENTIATING_T_LYMPHOCYTE | ARHGAP15 INPP4A ALMS1 ARHGEF6 KDM5A RBM33 SEC31B USF3 IPCEF1 AKAP13 | 1.01e-05 | 201 | 225 | 10 | M2200 |
| Coexpression | DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS | 2.09e-05 | 97 | 225 | 7 | M40301 | |
| Coexpression | NABA_MATRISOME | THSD4 RELN MUC21 IL16 LGALS9B CLEC7A COL6A5 FLG2 IGSF10 COL24A1 ANOS1 PXDN ANGPT4 ADAMTS18 CLEC10A TSPEAR LAMA4 MUC16 LGALS9 SERPINB2 MUC3A MUC4 SERPINA5 | 2.78e-05 | 1026 | 225 | 23 | M5889 |
| Coexpression | GSE14308_TH17_VS_INDUCED_TREG_UP | 6.15e-05 | 200 | 225 | 9 | M3385 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 6.15e-05 | 200 | 225 | 9 | M387 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN | 6.15e-05 | 200 | 225 | 9 | M9861 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 6.15e-05 | 200 | 225 | 9 | M7529 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN | 6.15e-05 | 200 | 225 | 9 | M5271 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | SLC28A3 SHKBP1 IGSF10 CACNB1 RNF135 CDC14A LGALS9 SEC24C RUBCN | 6.15e-05 | 200 | 225 | 9 | M6514 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DLGAP1 COL6A5 IGSF10 ARHGAP20 SCARA3 CACNB2 FAT3 LAMA4 ROBO1 MYO16 | 5.82e-08 | 192 | 227 | 10 | 3d0cb19f037f604253d7d728689aeaa94251e92b |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP15 CLEC7A SLC15A3 CD163 GK CLEC10A MUC16 PIK3R6 CD300E | 2.60e-07 | 172 | 227 | 9 | 72fbfa890995e47048b47199c170cc7dcd7661f8 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP15 CLEC7A SLC15A3 CD163 GK CLEC10A MUC16 PIK3R6 CD300E | 2.60e-07 | 172 | 227 | 9 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.32e-07 | 177 | 227 | 9 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.00e-07 | 181 | 227 | 9 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-07 | 184 | 227 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-07 | 184 | 227 | 9 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-07 | 184 | 227 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-07 | 184 | 227 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.76e-07 | 189 | 227 | 9 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-07 | 189 | 227 | 9 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDE4B ARHGAP15 CLEC7A CD163 GK ARHGEF6 PIK3R6 SIPA1L1 CD300E | 5.76e-07 | 189 | 227 | 9 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-07 | 189 | 227 | 9 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | RELN KIRREL3 ANOS1 ADARB2-AS1 IRX6 GRIP1 KIRREL1 UNC13C MYO16 | 6.02e-07 | 190 | 227 | 9 | be2b184a3559da41ba387ae0fdbeb9ae532868a5 |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | THSD4 DLGAP1 COL6A5 IGSF10 ARHGAP20 SCARA3 CACNB2 FAT3 MYO16 | 6.29e-07 | 191 | 227 | 9 | 14057205ddb9b4bbc582d1358d13cf36d979a61b |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.86e-07 | 193 | 227 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 6.86e-07 | 193 | 227 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-07 | 193 | 227 | 9 | a50ee6110ea272d9d9f41d48bb5d43711cc00a32 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.16e-07 | 194 | 227 | 9 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.16e-07 | 194 | 227 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.16e-07 | 194 | 227 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.16e-07 | 194 | 227 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.48e-07 | 195 | 227 | 9 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 390C-Myeloid|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.80e-07 | 196 | 227 | 9 | 5b690062db162e9ddd1a32b1be4d10f5f99c9407 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.49e-07 | 198 | 227 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.49e-07 | 198 | 227 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.85e-07 | 199 | 227 | 9 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | 356C-Myeloid|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.85e-07 | 199 | 227 | 9 | aca97ade3e4cc528315fa327e74a6245300f7b8c | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | CLEC7A SLC15A3 CD163 CKAP4 UBR4 MPEG1 RAB11FIP1 CCDC88A CD300E | 9.23e-07 | 200 | 227 | 9 | b5d197472799cc61d7497faed91ac2564ae4930a |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.23e-07 | 200 | 227 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 157 | 227 | 8 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-06 | 157 | 227 | 8 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.80e-06 | 161 | 227 | 8 | 0d863d7d369391dd6148e1de6d6f8033dcb8fe0f | |
| ToppCell | facs-MAT-Fat-3m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 164 | 227 | 8 | b81498c3934e0d52bf0329dc745e02966f9d8613 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 169 | 227 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 170 | 227 | 8 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 170 | 227 | 8 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 170 | 227 | 8 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 171 | 227 | 8 | af1c93eb75f45c042ea475d93db56e4da207e31f | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 172 | 227 | 8 | 6b01448443cf8392ed8248ff452b80c31240b85d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 172 | 227 | 8 | f6b4754a7e4b3e38030316a0ae00d932bfa87e41 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 172 | 227 | 8 | 0c0ae2da3cba6022403434567800f16e61a34a2b | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-06 | 172 | 227 | 8 | d80c207f3489be2da2f40f47a7835cb73c949c3e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.07e-06 | 173 | 227 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.64e-06 | 177 | 227 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 3.85e-06 | 126 | 227 | 7 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.95e-06 | 179 | 227 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-06 | 180 | 227 | 8 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.12e-06 | 180 | 227 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.12e-06 | 180 | 227 | 8 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-06 | 181 | 227 | 8 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.74e-06 | 130 | 227 | 7 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 186 | 227 | 8 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 186 | 227 | 8 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.45e-06 | 187 | 227 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.45e-06 | 187 | 227 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.45e-06 | 187 | 227 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-06 | 188 | 227 | 8 | 433a25fe52914e07e7ba695881f9bcca2d9467ff | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.67e-06 | 188 | 227 | 8 | fbf176b48b89c234e4e1e64739afc836bed78a96 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.13e-06 | 190 | 227 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.13e-06 | 190 | 227 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 191 | 227 | 8 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.37e-06 | 191 | 227 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 191 | 227 | 8 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.62e-06 | 192 | 227 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.62e-06 | 192 | 227 | 8 | 0219093e7921a0db78053aee13ec480b520f5662 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.62e-06 | 192 | 227 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.62e-06 | 192 | 227 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-06 | 192 | 227 | 8 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.62e-06 | 192 | 227 | 8 | bd3fa6c8fcb618db64d11f25cabaf08608957c35 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.69e-06 | 137 | 227 | 7 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-06 | 193 | 227 | 8 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.87e-06 | 193 | 227 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.87e-06 | 193 | 227 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.87e-06 | 193 | 227 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.14e-06 | 194 | 227 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-06 | 194 | 227 | 8 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-06 | 194 | 227 | 8 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | MS-granulo1-|MS / Condition, Cell_class and T cell subcluster | 7.41e-06 | 195 | 227 | 8 | eeaa2ecbcfbfb203c77261367b43ce55e786b312 | |
| ToppCell | 343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-06 | 195 | 227 | 8 | 169b4952118ca5ded55de928a1cf08721cdac193 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 7.41e-06 | 195 | 227 | 8 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.41e-06 | 195 | 227 | 8 | 0110b976f98561ecd2e20ff6e7e3960a401bb7c2 | |
| ToppCell | 390C-Myeloid-Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-06 | 195 | 227 | 8 | 6f09bfd6394c10c90c23d130a18941bf490e1a8f | |
| ToppCell | 367C-Myeloid-Monocyte-CD14+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-06 | 195 | 227 | 8 | 4f9e26e033353fc9a8bdbd10358ee68ab2291880 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 7.41e-06 | 195 | 227 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | MS-granulo1|MS / Condition, Cell_class and T cell subcluster | 7.41e-06 | 195 | 227 | 8 | 29688f55a6cdefbff4e818c20cb89473fbc16a59 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.41e-06 | 195 | 227 | 8 | 98ca9f3aa36211dde1e6f7f3817b9418c95e583e | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.41e-06 | 195 | 227 | 8 | 050fc59b328391d6e3ce23051764a842dcbb3144 | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.69e-06 | 196 | 227 | 8 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 7.69e-06 | 196 | 227 | 8 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | (3)_MNP|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.69e-06 | 196 | 227 | 8 | c79403da5443710a6caf035a279e42bc324b27c9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.69e-06 | 196 | 227 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.69e-06 | 196 | 227 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | distal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.69e-06 | 196 | 227 | 8 | 14c6870d125fc2bdacf4199883399cec0dd3f569 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.69e-06 | 196 | 227 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.69e-06 | 196 | 227 | 8 | c17bb7b3992bfec194bfa310f201a5c64b35868e | |
| ToppCell | Monocytes-IL1B+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.69e-06 | 196 | 227 | 8 | 7bc0735d324ac5a1661434cda4116ddd58296730 | |
| ToppCell | 367C-Myeloid-Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.69e-06 | 196 | 227 | 8 | 202066aeb837659fcc2e127fb52d7189e2e3520d | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 7.69e-06 | 196 | 227 | 8 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.69e-06 | 196 | 227 | 8 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| Disease | Colorectal Carcinoma | CSMD3 CABLES1 TXNRD1 KCNQ5 ADAMTS18 NR3C2 GNAS PHIP CACNB1 CACNB2 TSPEAR ZMIZ1 CUBN CDC14A HIVEP3 DUSP21 SLCO1A2 CD300E GABPB1 PROS1 ZNF292 EXOC4 | 2.39e-08 | 702 | 224 | 22 | C0009402 |
| Disease | serum gamma-glutamyl transferase measurement | THSD4 HDX SLC28A3 CSMD3 FCHO1 POM121 CLCNKB SVIL NAV2 KMT2A C3 NSMAF UGT1A8 RNF135 EBF1 ZMIZ1 SLCO1A2 COMMD7 ROBO1 AKAP13 ZNF292 EXOC4 | 2.09e-06 | 914 | 224 | 22 | EFO_0004532 |
| Disease | Bartter syndrome | 8.49e-06 | 6 | 224 | 3 | cv:C0004775 | |
| Disease | diet measurement | PDE4B ARHGAP15 KDM3B SLC28A3 RNF13 KIRREL3 GSDME KCNQ5 SLC35D3 ZNF770 NR3C2 TSPEAR LINGO2 EBF1 TPK1 COMMD7 ROBO1 ROBO2 UNC13C MYO16 EXOC4 | 5.54e-05 | 1049 | 224 | 21 | EFO_0008111 |
| Disease | Bartter disease type 4B | 5.74e-05 | 2 | 224 | 2 | cv:C4310805 | |
| Disease | Bartter disease type 3 (implicated_via_orthology) | 5.74e-05 | 2 | 224 | 2 | DOID:0110144 (implicated_via_orthology) | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 5.74e-05 | 2 | 224 | 2 | 613090 | |
| Disease | BARTTER SYNDROME, TYPE 4B | 5.74e-05 | 2 | 224 | 2 | C2751312 | |
| Disease | BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS | 5.74e-05 | 2 | 224 | 2 | C4310805 | |
| Disease | Bartter disease type 4b (is_implicated_in) | 5.74e-05 | 2 | 224 | 2 | DOID:0110146 (is_implicated_in) | |
| Disease | Bartter disease (implicated_via_orthology) | 5.74e-05 | 2 | 224 | 2 | DOID:445 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | THSD4 NAV2 ADAMTS18 CACNB2 RBBP5 FAT3 RNF135 NUP43 PM20D1 COMMD7 ROBO1 ROBO2 SH3RF3 EXOC4 | 8.86e-05 | 550 | 224 | 14 | EFO_0004346, EFO_0004464 |
| Disease | neuroticism measurement, cognitive function measurement | ARHGAP15 GATB FCHO1 NEDD9 NAV2 NR3C2 CACNA1E RBL2 PCLO PM20D1 NCOA5 SIPA1L1 GKAP1 EXOC4 | 1.20e-04 | 566 | 224 | 14 | EFO_0007660, EFO_0008354 |
| Disease | Growth abnormality | 1.71e-04 | 3 | 224 | 2 | C0262361 | |
| Disease | Amphetamine-Related Disorders | 2.70e-04 | 75 | 224 | 5 | C0236733 | |
| Disease | Amphetamine Abuse | 2.70e-04 | 75 | 224 | 5 | C0236807 | |
| Disease | Amphetamine Addiction | 2.70e-04 | 75 | 224 | 5 | C0236804 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 2.71e-04 | 17 | 224 | 3 | cv:C0270914 | |
| Disease | Feeding difficulties | 3.24e-04 | 18 | 224 | 3 | C0232466 | |
| Disease | lepromatous leprosy (is_marker_for) | 3.41e-04 | 4 | 224 | 2 | DOID:10887 (is_marker_for) | |
| Disease | cortical thickness | THSD4 RELN GATAD2A ANGPT4 NAV2 ADAMTS18 KMT2A FAT3 PM20D1 EBF1 GRIP1 VPS13D CCDC88A SLCO1A2 LRP11 ROBO1 ROBO2 SH3RF3 MYO16 EXOC4 | 3.46e-04 | 1113 | 224 | 20 | EFO_0004840 |
| Disease | neuroimaging measurement | THSD4 RELN GATAD2A COL24A1 NAV2 ADAMTS18 CACNB2 SZT2 RBBP5 FAT3 PM20D1 JPH1 CCDC88A LRP11 ROBO1 ROBO2 SH3RF3 MYO16 EXOC4 | 5.55e-04 | 1069 | 224 | 19 | EFO_0004346 |
| Disease | Bartter Disease | 5.65e-04 | 5 | 224 | 2 | C0004775 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement | 5.65e-04 | 5 | 224 | 2 | EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Neurodevelopmental Disorders | 7.29e-04 | 93 | 224 | 5 | C1535926 | |
| Disease | Abnormal muscle tone | 8.43e-04 | 6 | 224 | 2 | C0852413 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 8.77e-04 | 200 | 224 | 7 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | response to norepinephrine-dopamine reuptake inhibitor | 9.86e-04 | 26 | 224 | 3 | EFO_0007870 | |
| Disease | migraine disorder, type 2 diabetes mellitus | 1.13e-03 | 60 | 224 | 4 | MONDO_0005148, MONDO_0005277 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.17e-03 | 7 | 224 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | X-21339 measurement | 1.17e-03 | 7 | 224 | 2 | EFO_0800808 | |
| Disease | triacylglycerol 50:4 measurement | 1.51e-03 | 30 | 224 | 3 | EFO_0010411 | |
| Disease | Abnormality of the skeletal system | 1.56e-03 | 8 | 224 | 2 | C4021790 | |
| Disease | N2,N2-dimethylguanosine measurement | 1.56e-03 | 8 | 224 | 2 | EFO_0021125 | |
| Disease | level of Triacylglycerol (49:2) in blood serum | 1.56e-03 | 8 | 224 | 2 | OBA_2045162 | |
| Disease | Lymphoid leukemia | 1.56e-03 | 8 | 224 | 2 | C0023448 | |
| Disease | reaction time measurement | GATAD2A CDK19 GATB SLC28A3 RBKS COL24A1 POM121 NAV2 SLC5A12 PM20D1 AMBRA1 TPK1 DNAI4 | 1.67e-03 | 658 | 224 | 13 | EFO_0008393 |
| Disease | Microcephaly | 1.70e-03 | 67 | 224 | 4 | C0025958 | |
| Disease | eyelid sagging measurement | 1.82e-03 | 32 | 224 | 3 | EFO_0009360 | |
| Disease | Liver Diseases, Parasitic | 1.99e-03 | 9 | 224 | 2 | C0023897 | |
| Disease | marginal zone B-cell lymphoma, multiple sclerosis | 1.99e-03 | 9 | 224 | 2 | EFO_1000630, MONDO_0005301 | |
| Disease | Intellectual Disability | INPP4A KDM3B RNF13 KCNQ5 GNAS PHIP CACNA1E KDM5A ZMIZ1 ZNF292 | 2.33e-03 | 447 | 224 | 10 | C3714756 |
| Disease | DDT metabolite measurement | 2.46e-03 | 74 | 224 | 4 | EFO_0007886 | |
| Disease | nephrogenic diabetes insipidus (implicated_via_orthology) | 2.48e-03 | 10 | 224 | 2 | DOID:12387 (implicated_via_orthology) | |
| Disease | Pseudohypoaldosteronism, Type I | 2.48e-03 | 10 | 224 | 2 | C0268436 | |
| Disease | Pseudohypoaldosteronism | 2.48e-03 | 10 | 224 | 2 | C0033805 | |
| Disease | transverse temporal cortex volume measurement | 2.48e-03 | 10 | 224 | 2 | EFO_0010336 | |
| Disease | Hyperpotassemia and Hypertension, Familial | 2.48e-03 | 10 | 224 | 2 | C2713447 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Recessive | 2.48e-03 | 10 | 224 | 2 | C1449843 | |
| Disease | Pseudohypoaldosteronism, Type II | 2.48e-03 | 10 | 224 | 2 | C1449844 | |
| Disease | Pseudohypoaldosteronism, Type I, Autosomal Dominant | 2.48e-03 | 10 | 224 | 2 | C1449842 | |
| Disease | blood urea nitrogen measurement | DLGAP1 RBKS CLCNKB GNAS RAD17 EBF1 CDC14A FAM83B ROBO1 AKAP13 | 2.53e-03 | 452 | 224 | 10 | EFO_0004741 |
| Disease | intellectual disability (implicated_via_orthology) | 2.58e-03 | 75 | 224 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | age at first sexual intercourse measurement | PDE4B ARHGAP15 GABPB2 UNC79 VPS26B AMBRA1 GABPB1 ZNF292 EXOC4 | 2.76e-03 | 383 | 224 | 9 | EFO_0009749 |
| Disease | diverticulitis | 2.77e-03 | 37 | 224 | 3 | EFO_1001460 | |
| Disease | urate measurement, bone density | THSD4 ARHGAP15 RC3H1 COL6A5 NEDD9 KIRREL3 NR3C2 UGT1A8 RNF6 ROBO1 SH3RF3 MYO16 | 2.90e-03 | 619 | 224 | 12 | EFO_0003923, EFO_0004531 |
| Disease | alpha peak frequency measurement, alpha wave measurement, electroencephalogram measurement | 3.02e-03 | 11 | 224 | 2 | EFO_0004357, EFO_0006870, EFO_0006883 | |
| Disease | N-acetylphenylalanine measurement | 3.02e-03 | 11 | 224 | 2 | EFO_0800019 | |
| Disease | alcohol consumption measurement | RELN PDE4B ARHGAP15 FAM114A2 SLC28A3 RBKS CSMD3 INO80D SPTBN5 ALMS1 COBL NR3C2 CACNA1E PCLO DNAH2 LINGO2 GRIP1 COMMD7 LAMTOR3 | 3.10e-03 | 1242 | 224 | 19 | EFO_0007878 |
| Disease | verbal-numerical reasoning measurement | 3.31e-03 | 131 | 224 | 5 | EFO_0008394 | |
| Disease | smoking status measurement | DLGAP1 PDE4B GATAD2A ARHGAP15 GATB SLC28A3 RNF13 INO80D ALMS1 NAV2 HERC1 UNC79 FAT3 LINGO2 COMMD7 ROBO2 CEP295 EXOC4 | 3.41e-03 | 1160 | 224 | 18 | EFO_0006527 |
| Disease | Global developmental delay | 3.53e-03 | 133 | 224 | 5 | C0557874 | |
| Disease | smoking cessation | 3.55e-03 | 325 | 224 | 8 | EFO_0004319 | |
| Disease | alcoholic liver disease | 3.56e-03 | 82 | 224 | 4 | EFO_0008573 | |
| Disease | Oligospermia | 3.60e-03 | 12 | 224 | 2 | C0028960 | |
| Disease | Abnormality of the dentition | 3.60e-03 | 12 | 224 | 2 | HP_0000164 | |
| Disease | thyroxine measurement | 3.72e-03 | 83 | 224 | 4 | EFO_0005130 | |
| Disease | sleep measurement | 3.76e-03 | 135 | 224 | 5 | EFO_0004870 | |
| Disease | Charcot-Marie-Tooth disease | 3.98e-03 | 42 | 224 | 3 | cv:C0007959 | |
| Disease | testosterone measurement | KIF18A DLGAP1 PDE4B SLC28A3 CSMD3 NEDD9 KCNQ5 PHIP ARHGEF6 RNF19A UGT1A8 DNAH2 LINGO2 EBF1 ZMIZ1 UBE3D SLCO1A2 GKAP1 MYO16 | 4.10e-03 | 1275 | 224 | 19 | EFO_0004908 |
| Disease | fructose measurement | 4.24e-03 | 13 | 224 | 2 | EFO_0010477 | |
| Disease | bipolar I disorder | 4.52e-03 | 141 | 224 | 5 | EFO_0009963 | |
| Disease | bronchopulmonary dysplasia | 4.84e-03 | 45 | 224 | 3 | MONDO_0019091 | |
| Disease | alkaline phosphatase measurement | CYP2B6 ARHGAP15 GATB KIRREL3 POM121 NR3C2 CLEC10A HOMEZ FAM210A RBL2 EBF1 ZMIZ1 ZFAND4 HIVEP3 AKAP13 UNC13C | 4.89e-03 | 1015 | 224 | 16 | EFO_0004533 |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 4.92e-03 | 14 | 224 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | pulmonary function measurement, smoking behaviour measurement, FEV/FEC ratio | 5.47e-03 | 47 | 224 | 3 | EFO_0003892, EFO_0004713, EFO_0005671 | |
| Disease | diffuse plaque measurement | RELN PDE4B ARHGAP15 GATB CSMD3 KCNQ5 ADAMTS18 SLAIN1 CACNB2 RBBP5 EBF1 ROBO2 MYO16 | 5.51e-03 | 758 | 224 | 13 | EFO_0010699 |
| Disease | myeloid cell surface antigen CD33 measurement | 5.64e-03 | 15 | 224 | 2 | EFO_0008238 | |
| Disease | Proteinuria | 5.64e-03 | 15 | 224 | 2 | HP_0000093 | |
| Disease | intraocular pressure measurement | RELN COL24A1 ADAMTS18 KMT2A HERC2 ARHGAP20 LRP12 PCLO HIVEP3 AKAP13 | 5.79e-03 | 509 | 224 | 10 | EFO_0004695 |
| Disease | age at menarche | DLGAP1 KDM3B SLC28A3 KIRREL3 ALMS1 GABPB2 UNC79 DNAH2 FAM83B UNC13C GABPB1 | 5.99e-03 | 594 | 224 | 11 | EFO_0004703 |
| Disease | Cardiovascular Abnormalities | 6.42e-03 | 16 | 224 | 2 | C0243050 | |
| Disease | Rolandic epilepsy | 6.42e-03 | 16 | 224 | 2 | Orphanet_1945 | |
| Disease | unipolar depression, bipolar disorder | 6.90e-03 | 156 | 224 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | wellbeing measurement | KIRREL3 GSDME KMT2A NR3C2 HERC1 CACNA1E PCLO LINGO2 FAM83B NCOA5 UBE3D ELP4 | 6.93e-03 | 692 | 224 | 12 | EFO_0007869 |
| Disease | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | 7.24e-03 | 17 | 224 | 2 | EFO_0010543, EFO_0010544 | |
| Disease | response to homoharringtonine, cytotoxicity measurement | 7.24e-03 | 17 | 224 | 2 | EFO_0006952, EFO_0006996 | |
| Disease | blood cobalt measurement | 7.44e-03 | 101 | 224 | 4 | EFO_0007577 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 7.45e-03 | 447 | 224 | 9 | EFO_0000694, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSTSSIIQQYSGTRV | 981 | Q68DN1 | |
| SRNSAQGSFLVSVAE | 306 | Q6UXC1 | |
| SFRRVFSSSATAQGT | 91 | Q96ND0 | |
| SISTTQVFSLAGSTF | 606 | P55198 | |
| NTLSLFFAGTETTST | 291 | P20813 | |
| QGAVSSTVSGLQRQS | 136 | Q15052 | |
| SSSRLNYQSSVQGSS | 461 | Q9BWU1 | |
| TTTTASLAFTAAATQ | 136 | Q6UXZ3 | |
| LTVTSFNASTGRVNA | 3516 | Q7Z407 | |
| FNASTGRVNATLSNS | 3521 | Q7Z407 | |
| NAAFLTGSISNFSRA | 56 | A6NCI8 | |
| NRLSFSSTGSTRSNM | 366 | Q14511 | |
| SSDTTSNSFVRQGSA | 46 | Q02641 | |
| TFEAAVATSLGRSNT | 2251 | Q15878 | |
| QATFGTFESILRSSQ | 166 | Q07065 | |
| FANFSIVSGTTSITN | 736 | Q8IZF6 | |
| INRTSLSSGATVRSF | 461 | Q9UNH5 | |
| LSSGATVRSFSINSR | 466 | Q9UNH5 | |
| STGEVLTQNSGFRLS | 156 | Q496F6 | |
| LNLGGSSRVESQSSF | 101 | O60443 | |
| NATAVTTVRTNASGL | 16 | Q99678 | |
| SQAPASTSASTRLFG | 2761 | Q12802 | |
| SSSSVQQVTFSRGTD | 3246 | Q8TCU4 | |
| FTSSSGQQTAQRAEL | 646 | P01024 | |
| QRGDIISQSGLSNST | 576 | O14490 | |
| SSNSKLFSGSQVRFS | 76 | O75879 | |
| TTASRFALLQVDSGS | 11 | Q5VSY0 | |
| AQAATSLLASSASQF | 26 | A8MUL3 | |
| FSTVQSSTAGNTLRN | 371 | Q9C0C7 | |
| GRLSNTQGVVSAFST | 116 | P48047 | |
| QGFIRNDSSSSVAVS | 146 | Q8TE60 | |
| SDTTSNSFVRQGSAD | 61 | Q08289 | |
| ASQNTTFLTSGSILR | 586 | Q6IQ32 | |
| GRSSTFLSHSISNQA | 306 | Q8NFH3 | |
| ARGVGLNSTTQSVLS | 116 | Q5TC82 | |
| NFSSQGVTISLNATS | 81 | Q96EV2 | |
| GDIRSAINSLQFSSS | 331 | O75943 | |
| RGASQFLASASSSTT | 11 | P78412 | |
| AAAFSSQRSGLFTNT | 111 | P57740 | |
| NVTFKVTQATSSASA | 741 | Q96PE3 | |
| SSRSAVTASAGLAFQ | 231 | Q2M385 | |
| RNTTSEATFTLLGFS | 6 | Q8NGK9 | |
| TSTAFGNSNNILIAT | 856 | Q14207 | |
| SIGNTDSRFFTNLTT | 431 | Q6GTS8 | |
| SAQALAGSLSSQQVT | 781 | Q08999 | |
| FIAAVSVQAAGTQSS | 296 | Q9H477 | |
| DSFNVVSTRGSLRTQ | 1006 | O75808 | |
| LQSQASRSTISSSFG | 1651 | Q96PE2 | |
| LQNSASATALVSRTG | 551 | Q86YP4 | |
| VTQNSTAEPSRFSSS | 331 | O14526 | |
| LRLANSTVNSDGSVT | 296 | P23352 | |
| SSRTSISGFAQLTVS | 8161 | Q8WXI7 | |
| ASSQGTFTLDTSSRA | 8796 | Q8WXI7 | |
| GSETSAFSNLTVASS | 11216 | Q8WXI7 | |
| SLFVNGFTHRSSVST | 13746 | Q8WXI7 | |
| SSFLLQGRTAQTGSA | 4716 | Q99102 | |
| GNSTVASTAAVSSSF | 26 | P47900 | |
| SQSGATFFSISASSL | 456 | Q6PIW4 | |
| TQTGSRSSRASHFQS | 2316 | Q5D862 | |
| FILVGFQQSSTSTRA | 11 | Q8NGE0 | |
| LSRQTSVLNAGNSVF | 176 | Q7Z353 | |
| FQLTVTDTAGQRSSD | 276 | Q86VZ4 | |
| RFTLGRSSSLSQNQS | 741 | Q9Y561 | |
| GTISLSRSARDQSFQ | 531 | P08235 | |
| VDQGTSSTRFLVFNS | 16 | Q14409 | |
| LANTGVDTTSNSFSI | 2186 | Q2M2H8 | |
| TNSEFSTVSSGISIA | 91 | Q5SSG8 | |
| SRLSISGTGTSTFQR | 1761 | Q9Y6X6 | |
| VSSSVNQASRLIDGS | 2791 | O95714 | |
| STSNSSLTADVNSGF | 836 | Q8NI77 | |
| TSSSVSVISISAANF | 1411 | Q5HYC2 | |
| GSQARTSFSSVTVSR | 26 | Q5XKE5 | |
| LSRSTSANISRGLQF | 676 | Q9NR82 | |
| ITVNGAVLSSSGTRF | 31 | Q3B8N2 | |
| ITVNGTVLSSSGTRF | 31 | O00182 | |
| TVLSSSGTRFAVNFQ | 36 | O00182 | |
| VSAVQFGNSSTSVLA | 211 | Q06547 | |
| SISLAGSRLSSGFQS | 1656 | Q15751 | |
| GSRLSSGFQSSTLLT | 1661 | Q15751 | |
| SGFQSSTLLTSVRLQ | 1666 | Q15751 | |
| FLNVFVNSTSRSSST | 576 | Q13387 | |
| SRISSSDANSTISFG | 246 | Q9HDC5 | |
| QTASIATASASAQAR | 66 | Q96EX3 | |
| AFSTTAINFSTVNSS | 1531 | Q3V6T2 | |
| AINFSTVNSSAGFRS | 1536 | Q3V6T2 | |
| SSLASVSSQRNLFGR | 311 | Q5T0W9 | |
| QNFNSSARVSLSGSS | 291 | Q9Y5L3 | |
| ASIFSQASNLISTAG | 936 | Q9Y6V0 | |
| ESFTRGSTSTNAILT | 2661 | Q02505 | |
| HSSSLNNTSISRFGV | 316 | Q07343 | |
| LSLFNSGTVTANSSS | 436 | Q9HCD5 | |
| SSSIRQRISSFETFG | 836 | Q14005 | |
| QASGENSRNSILASS | 456 | Q7LBC6 | |
| AGTTRFFTSNTHSSV | 21 | Q9P2J3 | |
| SNAAGNDTFTASLTV | 486 | Q7L985 | |
| FETSSTRTDTQSGNL | 501 | Q6W3E5 | |
| SRFQRLSSTSSSGQQ | 91 | O94886 | |
| FQQSAFNRVVSSVSS | 1316 | P29375 | |
| TVAAFASSLVSGLNS | 186 | Q86U44 | |
| VASFRVTTGTSNTTA | 186 | Q15291 | |
| NSLFTVASASGAAST | 721 | P14859 | |
| LNTTTASVLQFSIGS | 256 | P78509 | |
| NAITSSYSSTRGISQ | 411 | Q96HA1 | |
| SAIQTSAGATANRFQ | 301 | Q6PI47 | |
| IRFTSDSSVTRAGFN | 2071 | O60494 | |
| TSSNTAVVRFVTDGS | 2421 | O60494 | |
| ASRTKSAFSNLSTSQ | 721 | Q96A65 | |
| LANQTVVSESSQGSR | 1781 | Q6WRI0 | |
| SFVTSESGFLNSLSS | 261 | Q8WWN9 | |
| TNAFGARRNTIDSTS | 406 | Q8TDN4 | |
| AGAFRSVSTSTTFVQ | 161 | P25686 | |
| RVAVFFSNGQTASRS | 1866 | A8TX70 | |
| FSNGQTASRSSIITA | 1871 | A8TX70 | |
| TGTIFTFRSARLNSQ | 366 | P05154 | |
| RTASRFSTGTLSNTA | 1221 | O75128 | |
| FSTGTLSNTADARQA | 1226 | O75128 | |
| SLNVSVSDGLFTSTA | 2466 | Q8TDW7 | |
| EFATTNQISLGSLRS | 56 | Q86VX2 | |
| VDQGTSSTRFLVFNS | 16 | P32189 | |
| SAGRQSSLVLQNTSF | 416 | Q9Y264 | |
| SQATNQGFTRNSSSV | 451 | Q9UH73 | |
| AFGVFSTISTAVQST | 151 | Q9NRY5 | |
| RFSASRSGNTASLTI | 81 | A0A075B6I4 | |
| SFIASSSANTGLIVS | 91 | Q9UHA4 | |
| TLGQFTRSVLGSSTV | 171 | Q5VTH9 | |
| FTVTGATATSTNNAS | 1006 | Q53TQ3 | |
| ITVSRNGSSVFTTSQ | 636 | Q92636 | |
| LSDTFSQGTQTRFSQ | 11 | Q96J84 | |
| NASVIFSLSQGRSVQ | 261 | P50053 | |
| VTNALGSTNLSRTVD | 316 | Q8IZU9 | |
| GNTYSRNNVSSVSTT | 2216 | Q03164 | |
| LFSRFGRSSTTQSSE | 761 | Q8NEL9 | |
| SSTSSSFQVLANGAT | 286 | Q8IX15 | |
| AFSTSQNGSLSQSSV | 861 | Q9Y4K1 | |
| SAVATASKSNVTSFQ | 16 | Q96EB1 | |
| SQLGRQASFQERSSS | 946 | Q9Y3R0 | |
| TTGRSSRQSSFIAVG | 1041 | Q86VB7 | |
| VQLSFTSLASAESGT | 1296 | Q9C0D2 | |
| TGFLTAVLQSSARQN | 4286 | Q9P225 | |
| RSSFSEGQTLTVTSG | 386 | Q92622 | |
| GSFRVTSSSSQFSSR | 561 | Q92622 | |
| FSVSSFSQITSGLSV | 1006 | P53992 | |
| AASSVRSNLTSFGAD | 171 | Q8IY34 | |
| ATLGASSQRISQNSE | 281 | Q6AZY7 | |
| VALGAAASTSQTSVQ | 161 | Q9NUM3 | |
| TAGSSSTRFIANSQE | 131 | Q9BUN1 | |
| DSATAFGAQTSSRLS | 401 | Q2VPK5 | |
| SFSQITRSLFLSNGV | 21 | Q9H596 | |
| SSARSVSQSRLGLSF | 91 | W6CW81 | |
| INISSSNEIISSRGF | 736 | Q3KNS1 | |
| SSRGFIQTTDVSSSA | 746 | Q3KNS1 | |
| LQLNGASITSASQTF | 1621 | Q16363 | |
| SFRSLSSAINASTGN | 106 | P05120 | |
| SQGSVLAFTRTFIAT | 511 | Q9GZY0 | |
| TGSQSLGVAISTRSF | 1116 | Q6ZUA9 | |
| QFSNSTTSVLATLAA | 216 | Q8TAK5 | |
| SGSSVSSQDSAFSQI | 946 | Q9P2F6 | |
| AFASSLSGSLATQAV | 101 | Q96GQ5 | |
| STQATGDSAFTSLSV | 1091 | Q5T011 | |
| DLLQRTGNFISTSTS | 216 | Q9Y5J1 | |
| TAAVVSRQGSSLNLF | 491 | Q6WKZ4 | |
| RFSTSQVLCSQALSS | 296 | Q8IUD6 | |
| RSFAGVAVLSTLQSS | 76 | Q5M8T2 | |
| QVSGASFSSLRQSVA | 346 | Q9BX59 | |
| SSSLQQAASRSPSFG | 251 | O95425 | |
| TLFISTNSGASAASR | 406 | Q9NYJ8 | |
| TVTRLTFSSAYQGNS | 86 | Q8IW70 | |
| TFIDSSGQFVSSQVT | 41 | Q969Y0 | |
| SGQFVSSQVTGISRN | 46 | Q969Y0 | |
| TNTSLSTSRDASVFQ | 1671 | Q8IZX4 | |
| ANSASVNAISLTSGI | 91 | Q5QGS0 | |
| VSLRSSSGVLFNQRS | 346 | Q7RTY7 | |
| GSSQFAAVAASSAVR | 251 | Q5JWF2 | |
| GSSSVFSVLSNSAEV | 46 | Q9UL19 | |
| GKSFSTVTNTFRTNN | 661 | Q5UE93 | |
| SGTRFNFSQLASPTT | 1561 | Q8IVL1 | |
| SSSNGFLGTSRISTN | 41 | Q7Z3Z4 | |
| SSRKNVFQITTVSGN | 151 | Q53QZ3 | |
| ASVSAQSFGALSESR | 316 | O43567 | |
| RTRSQTSVNFNGSSS | 196 | Q9Y252 | |
| SSPVTVRNSQSFDSS | 421 | Q8ND83 | |
| RRNTTTGASAAAVAS | 356 | O43166 | |
| SASQLFVRLSSTGQR | 516 | Q8TBC3 | |
| TGLSTSAIATNGFVR | 226 | Q13621 | |
| QDGLSTAVQTFSNRS | 66 | Q96JW4 | |
| ESTVSVSGNLSSNSF | 116 | P46721 | |
| TGTSAQQLDSSFSTN | 26 | Q9NQW1 | |
| FAGSTALSRSAVQES | 391 | P40879 | |
| ATQGASSSISLVANI | 436 | Q9HAS3 | |
| SLSASRSTNAQVFAT | 1596 | Q9P2P6 | |
| TDVFQRLGSNSALTT | 771 | Q5T5J6 | |
| RSGTSNSQSQAKTYT | 381 | O00444 | |
| SFQTGLFTAARQSTN | 91 | P07225 | |
| TVFQGDGTASTTLRN | 371 | Q96PQ1 | |
| ASARASLFTVNSALS | 811 | Q9NRC6 | |
| SFIQNLVSASLGSTS | 111 | Q13490 | |
| QRFLSTQVGSAIISS | 561 | Q7Z7M1 | |
| LNSTTSSSTTFGAFR | 16 | Q17RA5 | |
| TLRTDFSNFTSNTVA | 71 | Q8IUN9 | |
| DGSTFSSNLFQIRTT | 196 | Q9BXN2 | |
| STIAVRDSASNGSIF | 36 | Q8NCR9 | |
| VALVSFSSGFSQSIT | 101 | P51800 | |
| VALVSFSSGFSQSIT | 101 | P51801 | |
| SSNSGFDSSVASQIT | 251 | Q9UKZ1 | |
| RSQLSSLQSGNVSAV | 311 | Q17RW2 | |
| ATFQTTQGFIVTASR | 1336 | Q99570 | |
| STSGDVVSRNQSFLR | 61 | Q9H4B6 | |
| GFTSTATADSRALLQ | 46 | Q16881 | |
| QAAIASQRFEGTTSL | 306 | Q4G0F5 | |
| SSGTVQLTTTSRAEF | 246 | Q8IWS0 | |
| GRFRTLSQSTANESS | 831 | Q8NB66 | |
| IQFSNTSNRFVSGSR | 371 | Q8WWQ0 | |
| NSIFSTNTSSDNGLT | 106 | Q9NV58 | |
| SSSVANFLQARGLAS | 111 | Q6P1M0 | |
| TLSSSGAVSAFQRRV | 356 | Q8TEJ3 | |
| SLTSANVVLATNTGA | 341 | P38935 | |
| LSSARSTFRFTIQGQ | 261 | Q7Z6J8 | |
| STVVALSQARFSDGQ | 831 | Q92626 | |
| SQNFTSNSSRVSVIS | 1596 | O60281 | |
| SNVSLSGSSRSASFE | 936 | Q5T1R4 | |
| QSVTVLTVGSYNSTS | 741 | Q9HCK4 | |
| ATVNLTVSSSSYGSQ | 1271 | Q68DE3 | |
| SSSRFSVSQTGDLTI | 401 | Q9Y6N7 | |
| SSVASVAAGTSFQVL | 6 | Q86VD9 | |
| QSSEQTQRTFVGSLG | 376 | Q6IQ21 | |
| TQANTFASRVSSLAE | 56 | Q9Y6W5 | |
| QSATVLGTQIFTSGR | 326 | Q8N9V2 | |
| SVCNASFTTNGSLTR | 1026 | Q9UL36 | |
| ATRLFEANQTIATSG | 461 | Q8WU66 | |
| TLRASSGLQQTNFSS | 21 | Q86VR7 | |
| ATQSFSQPARSTAIS | 276 | Q6ZMP0 | |
| NISFLASLAGSTSRN | 566 | Q86XD8 | |
| TGTFALTSLISANAV | 101 | Q8TE54 | |
| AFSGTLSTVASSINA | 341 | Q1EHB4 | |
| TNRNQRSSSFGSVST | 21 | P57768 | |
| LRASVVTASSGSALQ | 3251 | Q5T4S7 | |
| GQTSRLSASSTFQSI | 1176 | Q14679 | |
| LFTLQTVNSNGTSDR | 716 | P51784 | |
| GSSSTSRNQVASLAY | 146 | Q96M66 | |
| TSGFVSSNQRNTTAT | 616 | Q9UPU9 | |
| NDVLAFGTLVSTSNT | 206 | Q9H3S4 | |
| RNFSSVAASSGNTTL | 711 | Q9ULJ6 | |
| TTRNNTSFNISEGIL | 161 | Q9NYW5 | |
| QVRSLFSLFLSSSNG | 101 | Q9HAW9 | |
| ARTLQGIGSSFSSVA | 196 | P54219 | |
| SVGRLASSTTFSNQA | 2051 | Q9P2D8 | |
| LSASQDGTLQSFSTV | 396 | Q8NI36 | |
| RVSQSFGLQTTSADR | 581 | Q5THJ4 | |
| SQTQASETLAVRGFS | 636 | Q5VVJ2 |